Loading…
Employees: 552
Size Ocumension Therapeutics (1477.HK) is a Hong Kong Industrials company (Miscellaneous Commercial Services) with a market value of $525M, the 744th largest of 891 Hong Kong companies the cockpit tracks. Shares closed at HK$5.05 on 6 Nov 2026.
Performance Over six months the shares fell 28.8%, against -3.8% for the median peer and -13.4% for the Hong Kong market (cap-weighted) — 5th lowest of 21 in its peer set.
Growth Revenue grew 77.5% over the last twelve months (peer median +9.0%); the operating margin is -13.5% (peer median 11.3%).
Valuation It trades at 3.7× enterprise value to sales against a peer median of 2.1× (7th most expensive of 21).
Capital Return on invested capital runs 12.5 points below its cost of capital (9.5% WACC).
Next results Next results expected around 19 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | HK$1.04B | HK$872M | HK$452M | HK$272M | HK$185M |
| Revenue growth | — | +93% | +66% | +47% | — |
| Gross profit | HK$482M | HK$382M | HK$233M | HK$150M | HK$116M |
| EBITDA | HK$28.7M | -HK$17.9M | -HK$236M | -HK$381M | -HK$483M |
| Net income | -HK$142M | -HK$172M | -HK$291M | -HK$420M | -HK$468M |
| Free cash flow | -HK$55.4M | -HK$138M | -HK$219M | -HK$259M | -HK$336M |
| Capital expenditure | HK$309M | HK$275M | HK$250M | HK$400M | HK$360M |
| Total debt | n/a | HK$209M | HK$27.4M | HK$152M | HK$33.2M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 1477.HK | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -3.3% | -1.6% | 10th lowest of 21 |
| 6-month return | -28.8% | -3.8% | 5th lowest of 21 |
| Distance from 52-week high | -43.5% | -23.6% | 6th lowest of 21 |
| Revenue growth (TTM) | +77.5% | +9.0% | 2nd highest of 21 |
| Operating margin | -13.5% | 11.3% | 3rd lowest of 21 |
| EV / Sales | 3.7× | 2.1× | 7th most expensive of 21 |
| ROIC minus cost of capital | -12.5 pp | +1.4 pp | 2nd lowest of 21 |
| Net debt / EBITDA | -9.5× | 1.0× | 2nd least indebted of 13 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Ocumension Therapeutics 1477.HK | Hong Kong | $525M | -29% | +78% | -13% | 3.7× | n/a | n/a |
| BTS BTS-B.ST | Sweden | $527M | +76% | -4% | 8% | 2.0× | 10.7% | +13.0% |
| Nippon Parking Development 2353.T | Japan | $527M | +8% | +11% | 21% | 2.0× | -7.8% | +11.3% |
| Posti POSTI.HE | Finland | $529M | +31% | 0% | 5% | 0.7× | -5.4% | -1.4% |
| Academy of Environmental Planning & Design Co., Ltd. Nanjing University 300864.SZ | China | $531M | 0% | +5% | 18% | 3.4× | 9.3% | +10.6% |
| Sporton International 6146.TWO | Taiwan | $531M | -24% | +8% | 30% | 3.6× | -6.6% | +5.0% |
| Prestige International 4290.T | Japan | $518M | -4% | +10% | 13% | 0.9× | -12.4% | +11.8% |
| Guangdong Brandmax Marketing 300805.SZ | China | $533M | -19% | +13% | 1% | 1.1× | n/a | n/a |
| Restore RST.L | United Kingdom | $534M | +14% | +8% | 13% | 2.0× | 5.5% | +10.8% |
| Weathernews 4825.T | Japan | $534M | -11% | +5% | 21% | 2.8× | 3.4% | +5.4% |
| adesso ADN1.DE | Germany | $513M | +31% | +13% | 4% | 0.5× | 2.1% | +22.9% |
| Western Regions Tourism Development 300859.SZ | China | $513M | -30% | -13% | 15% | 12.0× | 38.8% | +44.7% |
| Pony Testing 300887.SZ | China | $513M | -35% | -2% | -12% | 2.1× | n/a | n/a |
| TKP 3479.T | Japan | $538M | +18% | +51% | 9% | 1.0× | -3.3% | +21.5% |
| Diversified Royalty DIV.TO | Canada | $507M | -6% | +15% | 86% | 17.9× | 13.0% | +18.3% |
| Italian Exhibition IEG.MI | Italy | $505M | +14% | +4% | 18% | 2.1× | -4.8% | +28.4% |
| MHA MHA.L | United Kingdom | $504M | -4% | +12% | 15% | 1.5× | -15.0% | +30.6% |
| Shanghai Model Organisms Center 688265.SS | China | $503M | +7% | +14% | -1% | 5.5× | n/a | n/a |
| Zhejiang Zoenn Design 300901.SZ | China | $549M | -5% | +53% | 10% | 7.5× | n/a | n/a |
| Xuanzhu Biopharmaceutical 2575.HK | Hong Kong | $553M | -59% | +237% | -187% | 31.5× | n/a | n/a |
| Hunan Airbluer Environmental Protection Technology 301259.SZ | China | $498M | -47% | -43% | -17% | 23.1× | n/a | n/a |